For the year ending 2025-12-31, MREO made $500K in revenue. -$33,852K in net income. Net profit margin of -6770.40%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 500 | - | ||
| Cost of revenue | 133 | - | ||
| Research and development | 17,766 | 20,930 | ||
| General and administrative | 23,008 | 26,434 | ||
| Other income | 300 | - | ||
| Loss from operations | -40,107 | -47,364 | ||
| Interest income | 2,173 | 3,041 | ||
| Interest expense | 255 | 1,370 | ||
| Changes in the fair value of warrants | 805 | -419 | ||
| Foreign currency transaction (loss)/gain, net | -6,344 | 1,210 | ||
| Benefit from research and development tax credit | 1,850 | 1,649 | ||
| Net loss before income tax | -41,878 | -43,253 | ||
| Income tax benefit | 0 | - | ||
| Net loss | -41,878 | -43,253 | ||
| Other comprehensive income/(loss) - foreign currency translation adjustments, net of tax | 8,026 | -1,364 | ||
| Total comprehensive loss | -33,852 | -44,617 | ||
| Basic EPS | -0.05 | -0.06 | ||
| Diluted EPS | -0.05 | -0.06 | ||
| Basic Average Shares | 797,119,632 | 739,624,264 | ||
| Diluted Average Shares | 797,119,632 | 739,624,264 | ||
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO)